The noteworthy changes in sialylation and GalNAc composition that we have described in blood serum PSA from aggressive PCa could be a reflection of changes that occur in the N-glycan biosynthesis pathways from prostate cancer cells. The gene discussed is KLK3; the disease is prostate carcinoma.